Annual Revenue
$2.22 M
-$9.27 M-80.71%
December 31, 2022
Summary
- As of February 10, 2025, RETA annual revenue is $2.22 million, with the most recent change of -$9.27 million (-80.71%) on December 31, 2022.
- During the last 3 years, RETA annual revenue has fallen by -$24.30 million (-91.64%).
Performance
RETA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$22.75 M
+$22.55 M+11564.62%
June 30, 2023
Summary
- As of February 10, 2025, RETA quarterly revenue is $22.75 million, with the most recent change of +$22.55 million (+11564.62%) on June 30, 2023.
- Over the past year, RETA quarterly revenue has increased by +$21.98 million (+2885.04%).
Performance
RETA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$23.48 M
+$21.98 M+1468.54%
June 30, 2023
Summary
- As of February 10, 2025, RETA TTM revenue is $23.48 million, with the most recent change of +$21.98 million (+1468.54%) on June 30, 2023.
- Over the past year, RETA TTM revenue has increased by +$13.48 million (+134.81%).
Performance
RETA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RETA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.7% | +2885.0% | +134.8% |
| 3 y3 years | -91.6% | +640.2% | +53.1% |
| 5 y5 years | -95.4% | +200.4% | -11.4% |
RETA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -80.7% | at low | at high | -99.1% | at high | -93.6% |
| 5 y | 5-year | -91.6% | at low | at high | -99.1% | -11.4% | -93.6% |
| alltime | all time | -95.9% | at low | -29.8% | -99.1% | -65.3% | -93.6% |
Reata Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $22.75 M(>+9900.0%) | $23.48 M(+1468.5%) |
| Mar 2023 | - | $195.00 K(-63.9%) | $1.50 M(-52.5%) |
| Dec 2022 | $2.22 M(-80.7%) | - | - |
| Sep 2022 | - | $540.00 K(-29.1%) | $3.15 M(-68.5%) |
| Jun 2022 | - | $762.00 K(-16.6%) | $10.00 M(-12.7%) |
| Mar 2022 | - | $914.00 K(-2.0%) | $11.46 M(-0.3%) |
| Dec 2021 | $11.49 M(+27.4%) | $933.00 K(-87.4%) | $11.49 M(-16.4%) |
| Sep 2021 | - | $7.39 M(+232.8%) | $13.75 M(+77.2%) |
| Jun 2021 | - | $2.22 M(+135.3%) | $7.76 M(-9.9%) |
| Mar 2021 | - | $944.00 K(-70.4%) | $8.61 M(-4.5%) |
| Dec 2020 | $9.02 M(-66.0%) | $3.19 M(+127.8%) | $9.02 M(+6.1%) |
| Sep 2020 | - | $1.40 M(-54.4%) | $8.50 M(-44.6%) |
| Jun 2020 | - | $3.07 M(+127.1%) | $15.34 M(-23.7%) |
| Mar 2020 | - | $1.35 M(-49.3%) | $20.10 M(-24.2%) |
| Dec 2019 | $26.52 M(-50.5%) | $2.67 M(-67.6%) | $26.52 M(-17.9%) |
| Sep 2019 | - | $8.24 M(+5.2%) | $32.30 M(+10.5%) |
| Jun 2019 | - | $7.83 M(+0.8%) | $29.23 M(+0.9%) |
| Mar 2019 | - | $7.77 M(-8.1%) | $28.97 M(-45.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $53.59 M(+11.5%) | $8.45 M(+63.3%) | $53.59 M(-2.7%) |
| Sep 2018 | - | $5.17 M(-31.6%) | $55.10 M(-11.8%) |
| Jun 2018 | - | $7.57 M(-76.6%) | $62.48 M(-7.7%) |
| Mar 2018 | - | $32.39 M(+225.1%) | $67.72 M(+40.9%) |
| Dec 2017 | $48.06 M(-3.6%) | $9.96 M(-20.6%) | $48.06 M(-5.0%) |
| Sep 2017 | - | $12.56 M(-1.9%) | $50.60 M(+0.0%) |
| Jun 2017 | - | $12.81 M(+0.6%) | $50.59 M(+0.9%) |
| Mar 2017 | - | $12.73 M(+1.8%) | $50.15 M(+0.6%) |
| Dec 2016 | $49.86 M(-0.9%) | $12.50 M(-0.4%) | $49.86 M(-0.0%) |
| Sep 2016 | - | $12.55 M(+1.5%) | $49.88 M(+0.1%) |
| Jun 2016 | - | $12.37 M(-0.6%) | $49.83 M(+0.0%) |
| Mar 2016 | - | $12.44 M(-0.7%) | $49.83 M(-1.0%) |
| Dec 2015 | $50.32 M(-3.1%) | $12.53 M(+0.2%) | $50.32 M(-0.4%) |
| Sep 2015 | - | $12.50 M(+1.1%) | $50.50 M(+32.9%) |
| Jun 2015 | - | $12.37 M(-4.4%) | $38.00 M(+48.2%) |
| Mar 2015 | - | $12.93 M(+1.7%) | $25.64 M(+101.7%) |
| Dec 2014 | $51.95 M(+1.5%) | $12.71 M | $12.71 M |
| Dec 2013 | $51.20 M | - | - |
FAQ
- What is Reata Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals annual revenue year-on-year change?
- What is Reata Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals quarterly revenue year-on-year change?
- What is Reata Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals TTM revenue year-on-year change?
What is Reata Pharmaceuticals annual revenue?
The current annual revenue of RETA is $2.22 M
What is the all time high annual revenue for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high annual revenue is $53.59 M
What is Reata Pharmaceuticals annual revenue year-on-year change?
Over the past year, RETA annual revenue has changed by -$9.27 M (-80.71%)
What is Reata Pharmaceuticals quarterly revenue?
The current quarterly revenue of RETA is $22.75 M
What is the all time high quarterly revenue for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high quarterly revenue is $32.39 M
What is Reata Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, RETA quarterly revenue has changed by +$21.98 M (+2885.04%)
What is Reata Pharmaceuticals TTM revenue?
The current TTM revenue of RETA is $23.48 M
What is the all time high TTM revenue for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high TTM revenue is $67.72 M
What is Reata Pharmaceuticals TTM revenue year-on-year change?
Over the past year, RETA TTM revenue has changed by +$13.48 M (+134.81%)